Research Policy Analysis and Coordination
Parent: UC Office of the President
eScholarship stats: Breakdown by Item for July through October, 2026
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 9st228b4 | UC Response to NIH Pause on New Submissions to the NIH Human Embryonic Stem Cell Registry and Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research (NOT-OD-26-031) | 126 | 8 | 118 | 6.3% |
| 89w7t4r0 | UC Comments to NSF on Common Disclosure Forms for the Biographical Sketch and Current and Pending (Other) Support | 83 | 3 | 80 | 3.6% |
| 442553qv | UC Comments on NIH's Request for Information on Proposed Changes to Reporting Outcomes from NIH Peer Review | 77 | 34 | 43 | 44.2% |
| 9vw6z5h0 | UC Comments on NIH/OLAW's RFI on Update to NOT-OD-05-034 Guidance on Prompt Reporting of Noncompliances to OLAW (NOT-OD-23-063) | 71 | 5 | 66 | 7.0% |
| 52s372wx | University of California System Comments on Proposed Rule, Regulation for Federal Financial Assistance, 91 Fed. Reg. 32198, published May 29, 2026 (Docket ID No. OMB-2026-0034) | 56 | 14 | 42 | 25.0% |
| 3x1637k7 | UC Comments on USPTO's Notice of Proposed Rulemaking on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (Docket No. PTO-P-2024-0003) | 54 | 7 | 47 | 13.0% |
| 7br0n9jb | UC Comments in Response to NOT-OD-23-034, "Request for Information (RFI) on Proposed Simplified Review Framework for NIH Research Project Grant Application" | 54 | 9 | 45 | 16.7% |
| 5bv354tk | University of California System Comments on Draft NSF Guidance on FinancialAssistance, Information Collection No. 3145-0058, Docket ID No. NSF-2026-OTR-0001 | 53 | 10 | 43 | 18.9% |
| 5dt1t3xd | UC Comments on OSTP RFI on NSPM 33 Research Security Program Standard Requirement (88 FR 14187) | 53 | 5 | 48 | 9.4% |
| 3367v4kt | UC Comments in Response to OMB’s Request for Information for Revisions to 2 CFR, Subtitle A, Chapters I and II (88 FR 8480) | 52 | 6 | 46 | 11.5% |
| 6th4n833 | UC Comments in Response to 88 FR 8374, "OMB Guidance for Grants and Agreements" | 51 | 4 | 47 | 7.8% |
| 7d17013p | UC Comments on AAALAC International's Draft Position Statement on "The 3Rs" | 51 | 3 | 48 | 5.9% |
| 47w4329h | UC Request for a 60-day Extension to Submit Comments on NASA "New Conflict of Interest and Conflict of Commitment Policy for Recipients of NASA Financial Assistance Awards" | 48 | 4 | 44 | 8.3% |
| 24b9t00t | University of California Response to Office of Science and Technology Policy (OSTP) Request for Information on Accelerating the American Scientific Enterprise (Docket ID No. OSTP-TECH-2025-0100) | 47 | 4 | 43 | 8.5% |
| 7388t27t | UC Comments on Agency Information Collection Activities; Comment Request; Foreign Gifls and Contracts Disclosures | 46 | 4 | 42 | 8.7% |
| 7f05k19f | UC Comments on DEA's Advanced Notice of Proposed Rulemaking on Controlled Substance Destruction Alternatives to Incinceration (RIN 1117-AB84/Docket No. DEA-1144) | 46 | 7 | 39 | 15.2% |
| 9vd827xq | UC Comments on Draft OHRP Guidance on Use of a Single Institutional Review Board for Cooperative Research (Docket ID Number HHS-OASH-2022-0011, July 1, 2022) | 46 | 6 | 40 | 13.0% |
| 5qq5413q | UC Comments in Response to 2024-16501 (89 FR 60980) & 2024-22041 (89 FR 78278), International Traffic in Arms Regulations: Revisions to Definition and Controls Related to Defense Services (July 29, 2024), RIN 0694-AI35 | 45 | 6 | 39 | 13.3% |
| 3656b1x3 | UC Comments on 2nd Notice of Proposed Regulation Amendments: Addition of Section100650 to Chapter 6 of Title 17 of the California Code of Regulations,and the California Institute of Regenerative Medicine (“CIRM”) IP Policyincorporated by reference into Section 100650 | 44 | 8 | 36 | 18.2% |
| 2s80v71k | National Science Foundation Proposal/Award Information – NSF Proposal and Award Policies and Procedures Guide | 43 | 6 | 37 | 14.0% |
| 31h4n0qg | UC Comments to AAALAC International's Proposed Revisions to Their Position Statement on "The Attending Veterinarian and Veterinary Care" | 43 | 5 | 38 | 11.6% |
| 49w3t150 | UC Comments on OSTP's RFI on Proposed Changes to DURC and P3CO Policies [Docket ID (EOP-2023-0001)] | 43 | 7 | 36 | 16.3% |
| 99n0x1kk | UC Comments on NIH/OLAW's RFI on Proposed Guidance to Assured Insitutions on Cephalopod Care and Use (NOT-OD-23-176) | 43 | 6 | 37 | 14.0% |
| 0gr9367z | UC Comments in Response to the NIH Request for Information: Developing Consent Language for Future Use of Data and Biospecimens (NOT-OD-21-131) | 42 | 12 | 30 | 28.6% |
| 4bm8874s | UC Comments on the Notice of Proposed Regulation Adoption: Addition of Section100505 (CIRM Award Management Policy) to Chapter 5 of Title 17 of the California Code of Regulations | 42 | 4 | 38 | 9.5% |
| 93g1s074 | UC Comments on Controls To Enhance the Cultivation of Marihuana for Research in the United States (Docket No. DEA-2020-0008, March 23, 2020) | 42 | 5 | 37 | 11.9% |
| 9bs081jb | UC Comments on the Senate HELP Committee Letter, Dated September 29, 2023, Seeking Input on Modernizing NIH | 42 | 6 | 36 | 14.3% |
| 19t30344 | University of California Response to NIH Request for Information on Maximizing Research Funds by Limiting Allowable Publishing Costs (NOT-OD-25-138) | 41 | 5 | 36 | 12.2% |
| 5ws0k723 | UC Comments on Defense Federal Acquisition Regulation Supplement: Assessing Contractor Implementation of Cybersecurity Requirements (DFARS Case 2019-D041/RIN 0750-AK81; Docket DARS-2020-0034) | 41 | 5 | 36 | 12.2% |
| 29q041pz | UC Comments on Supplemental notice of proposed rulemaking: Strengthening Transparency in Regulatory Science (Docket ID EPA-HQ-OA-2018-0259) | 40 | 4 | 36 | 10.0% |
| 3gg7b6cs | UC Request for a 60-day Extension to Submit Comments on OMB's Request for Information for Revisions to 2 CFR, Subtitle A, Chapters I and II | 40 | 5 | 35 | 12.5% |
| 9gk3c9s4 | UC Comments on Third Notice of Proposed Regulation Amendments: Addition of Section 100650 to Chapter 6 of Title 17 of the California Code of Regulations, and the California Institute of Regenerative Medicine (“CIRM”) IP Policy incorporated by reference into Section 100650 | 40 | 6 | 34 | 15.0% |
| 9sn6m48b | UC Comments on FDA's Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability (Docket No. FDA-2021-D-1214, December 9, 2021) | 40 | 6 | 34 | 15.0% |
| 36w0q7bp | National Aeronautics and Space Administration Reporting Requirements Regarding Findings ofHarassment, Sexual Harassment, Other Forms of Harassment, or Sexual Assault (FR Doc. 2019-15088) | 39 | 4 | 35 | 10.3% |
| 3qf4328f | UC Comments on GSA's Information Collection 3090-0291, FSRS Registration Requirements for Prime Grant Awardees (89 FR 14842) | 38 | 6 | 32 | 15.8% |
| 5193z036 | UC Comments on Notice of Proposed Regulation Amendments: Addition of Section 100650 to Chapter 6 of Title 17 of the California Code of Regulations, and the California Institute of Regenerative Medicine (“CIRM”) IP Policy incorporated by reference into Section 100650 | 38 | 6 | 32 | 15.8% |
| 59z9m16x | UC Comments on AAALAC International's Draft Position Statement on "The Culture of Care" | 38 | 4 | 34 | 10.5% |
| 6546b70g | UC Comments in Response to Notice of Proposed Rulemaking on Provisions Pertaining to Precenting Access to the U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons (Docket No. NSD 104) | 38 | 4 | 34 | 10.5% |
| 3591b3jz | UC Comments on FDA Guidance Document: Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices (FDA-2021-D-0368) | 37 | 5 | 32 | 13.5% |
| 36d5w13t | UC Comments on NIST's RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No.: 230831-0207) | 37 | 5 | 32 | 13.5% |
| 4rw9g2k6 | University of California Response to NIH Request for Information on Draft NIHControlled-Access Data Policy and Proposed Revisions to NIH Genomic Data Sharing Policy(NOT-OD-26-023) | 37 | 4 | 33 | 10.8% |
| 6p60f04g | UC Comments on California Department of Justice Notice of Modification to Text of Proposed Regulations regarding the Controlled Substance Utilization Review and Evaluation System (CURES) at Title 11, Division 1, Chapter 8.5 Issued on January 16, 2020 | 37 | 3 | 34 | 8.1% |
| 8k93x8wq | UC Comments on Helium Supply Risk (DOI-2022-0012) | 37 | 5 | 32 | 13.5% |
| 74v35572 | UC Request for A 60-day Extension to Submit Comments on Proposed Revisions to the OMB Guidance for Grants and Agreements | 36 | 4 | 32 | 11.1% |
| 79k487nr | UC Comments on Agency Information Collection Request - Foreign Gifts and Contracts Disclosures | 36 | 4 | 32 | 11.1% |
| 7v11n0rm | UC Comments on FDA Docket No. FDA-2019-N-2175 for “Institutional Review Boards; Cooperative Research.” (September 28, 2022) | 36 | 8 | 28 | 22.2% |
| 06g5v1tp | UC Comments in Response to 2024-16496 (89 FR 60985) & 2024-22146 (89 FR 78835), End-Use and End-User Based Export Controls, Including U.S. Persons Activities Controls: Military and Intelligence End Use and End Users (July 29, 2024), RIN 0694-AJ43 | 35 | 4 | 31 | 11.4% |
| 0rw2x9gj | UC Comments on ED's Request for Comments on Agency Information Collection Activities: Foreign Gifts and Contracts Disclosures (HEA Section 117) (Docket ID Number ED-2022-SCC-0159) | 35 | 5 | 30 | 14.3% |
| 1cz5808q | UC Comments on Agency Information Collection Activities; Comment Request; Foreign Gifts and Contracts Disclosures (Docket ID ED-2019-ICCD-0114) | 35 | 4 | 31 | 11.4% |
| 8m65c5h9 | UC Comments in Response to NOT-OD-21-018, “Request for Information (RFI):Inviting Comments and Suggestions on the NIH-Wide Strategic Plan for COVID-19 Research” | 35 | 3 | 32 | 8.6% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.